CAS 180185-61-9

(2R,4S)-(-)-N-[4-(Diethoxyphosphorylmethyl)phenyl]-4-methyl-7,8-(methylenedioxy)-5-oxo-1,2,4,5-tetrahydro-3-benzothiepine-2-carboxamide

Description:

The chemical substance with the name "(2R,4S)-(-)-N-[4-(Diethoxyphosphorylmethyl)phenyl]-4-methyl-7,8-(methylenedioxy)-5-oxo-1,2,4,5-tetrahydro-3-benzothiepine-2-carboxamide" and CAS number "180185-61-9" is a complex organic compound characterized by its unique stereochemistry and functional groups. It features a tetrahydro-benzothiepine core, which is a bicyclic structure that includes a sulfur atom, contributing to its potential biological activity. The presence of a diethoxyphosphorylmethyl group indicates that it may exhibit phosphonate characteristics, which can enhance its reactivity and interaction with biological targets. The methylenedioxy group suggests potential for additional reactivity or interaction with biological systems, while the carboxamide functional group may influence solubility and hydrogen bonding capabilities. Overall, this compound's intricate structure and functional groups suggest it could be of interest in medicinal chemistry, particularly in the development of pharmaceuticals or agrochemicals, although specific biological activities would require further investigation.

Formula: C₂₄H₂₈NO₇PS

Synonyms:

• Tak-778-Sr
• Tak-778
• (6R,8S)-(-)-N-[4-(Diethoxyphosphorylmethyl)phenyl]-8-methyl-9-oxo-5,6,8,9-tetrahydrothiepino[4,5-f]-1,3-benzodioxole-6-carboxamide

TAK-778

CAS: 180185-61-9

TAK-778, a derivative of ipriflavone, demonstrates the ability to stimulate bone growth in both in vitro and in vivo models.

Formula: C₂₄H₂₈NO₇PS

Purity: 98%

Color and Shape: Solid

Molecular weight: 505.52

Ref: TM-T13913

TAK 778

Controlled Product

CAS: 180185-61-9

Formula: C₂₄H₂₈NO₇PS

Color and Shape: Neat

Molecular weight: 505.52

Ref: TR-T004885

TAK 778

CAS: 180185-61-9

TAK 778 is an orally bioavailable small molecule that has been shown to inhibit the activity of phosphatase and act as a cavity-forming agent. TAK 778 has been shown to increase bone growth in vivo and enhance bone repair in vitro. This drug also stimulates the proliferation of human osteoblasts when used in vitro, which is likely due to its ability to inhibit the activity of phosphatase. TAK 778 is capable of inducing insulin-like growth factor-I (IGF-I) production by cultured hepatocytes, which may be due to its inhibition of phosphatase.

Formula: C₂₄H₂₈NO₇PS

Purity: Min. 95%

Molecular weight: 505.5 g/mol

Ref: 3D-FHA18561